BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15264009)

  • 1. In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203).
    Villar LM; Amado LA; Gaspar AM
    Braz J Med Biol Res; 2004 Jul; 37(7):1023-7. PubMed ID: 15264009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
    Yap KL; Lam SK
    J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In situ enzyme immunoassay for detection of hepatitis A virus].
    Hou Z; Yan J; Long R
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):362-4. PubMed ID: 12759978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-antibody in situ enzyme immunoassay for infectivity titration of hepatitis A virus.
    Borovec S; Uren E
    J Virol Methods; 1997 Oct; 68(1):81-7. PubMed ID: 9395142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Real-Time Cell Analysis (RTCA) Method as a Fast and Accurate Method for Detecting Infectious Particles of the Adapted Strain of Hepatitis A Virus.
    Lebourgeois S; Fraisse A; Hennechart-Collette C; Guillier L; Perelle S; Martin-Latil S
    Front Cell Infect Microbiol; 2018; 8():335. PubMed ID: 30319992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations.
    Konduru K; Virata-Theimer ML; Yu MY; Kaplan GG
    Virol J; 2008 Dec; 5():155. PubMed ID: 19094229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay.
    Azizi A; Sirskyj D; Weltzin R; Anderson DE; Diaz-Mitoma F
    J Med Microbiol; 2009 Nov; 58(Pt 11):1433-1436. PubMed ID: 19608692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary isolation of a Brazilian strain of hepatitis A virus (HAF-203) and growth in a primate cell line (FRhK-4).
    Gaspar AM; Vitral CL; Yoshida CF; Schatzmayr HG
    Braz J Med Biol Res; 1992; 25(7):697-705. PubMed ID: 1342600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of a novel TaqMan real-time reverse transcription-polymerase chain reaction assay for hepatitis A virus detection.
    Qiu F; Zheng H; Yi Y; Jia Z; Cao J; Bi S
    J Int Med Res; 2013 Apr; 41(2):427-34. PubMed ID: 23569019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrared fluorescent immunofocus assay (IR-FIFA) for the quantitation of non-cytopathic and minimally cytopathic viruses.
    Counihan NA; Daniel LM; Chojnacki J; Anderson DA
    J Virol Methods; 2006 Apr; 133(1):62-9. PubMed ID: 16300833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
    Krah DL
    Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast growth of a Brazilian hepatitis A virus (HAF-203) in a primate cell line.
    Gaspar AM; Vitral CL; Yoshida CF; Schatzmayr HG
    Braz J Med Biol Res; 1993 Feb; 26(2):203-6. PubMed ID: 8257921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable growth of wild-type hepatitis A virus in cell culture.
    Konduru K; Kaplan GG
    J Virol; 2006 Feb; 80(3):1352-60. PubMed ID: 16415012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titration of human coronaviruses using an immunoperoxidase assay.
    Lambert F; Jacomy H; Marceau G; Talbot PJ
    J Vis Exp; 2008 Apr; (14):. PubMed ID: 19066576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of hepatitis A virus strain HAF-203 isolated in Brazil and expression of the VP1 gene in Escherichia coli.
    Baptista ML; Silva M; Lima MA; Yoshida CF; Gaspar AM; Galler R
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):759-66. PubMed ID: 17160284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate.
    Pinto MA; Marchevsky RS; Baptista ML; de Lima MA; Pelajo-Machado M; Vitral CL; Kubelka CF; Pissurno JW; Franca MS; Schatzmayr HG; Gaspar AM
    Exp Toxicol Pathol; 2002 Feb; 53(6):413-20. PubMed ID: 11930901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor.
    Sun MB; Jiang YJ; Li WD; Li PZ; Li GL; Jiang SD; Liao GY
    World J Gastroenterol; 2004 Sep; 10(17):2571-3. PubMed ID: 15300909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemiluminescent focus assays for the quantitation of hepatitis A virus and rotavirus in cell cultures.
    Richards GP; Watson MA
    J Virol Methods; 2001 May; 94(1-2):69-80. PubMed ID: 11337041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.